Overview
KRMD market data
Price History
KRMD price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.06 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.35 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -4.0% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $3.21 – $6.61 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $153.5M · P/B 15.79 · P/S 3.40.
Company News
8-K filing — KORU Medical Systems, Inc. (KRMD)SEC EDGAR · Aug 14, 2026, 8:01 PM
Koru Medical Systems Withdraws 510(K) Application For FreedomEDGE With Phesgo In U.S. To Focus On Alternative Higher Volume MoleculesBenzinga · Aug 5, 2026, 10:48 PM
KORU Medical Systems Narrows FY2026 Sales Guidance from $47.500M-$50.000M to $47.500M-$48.500M vs $48.688M EstBenzinga · Aug 5, 2026, 8:24 PM
KORU Medical Systems Q2 Adj. EPS $0.02 Beats $(0.02) Estimate, Sales $12.045M Beat $11.609M EstimateBenzinga · Aug 5, 2026, 8:08 PM
KORU Medical Systems Presents Data Titled 'Reducing Ergonomic Strain During Subcutaneous Monoclonal Antibody Administration' At Oncology Nursing Society CongressBenzinga · May 18, 2026, 8:15 PM